Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

60; Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2011, which is on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries, including Regulus Therapeutics Inc., its jointly owned subsidiary.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.ISIS PHARMACEUTICALS, INC.SELECTED FINANCIAL INFORMATIONCondensed Consolidated Statements of Operations(In Thousands, Except Per Share Data)Three months ended,March 31,20122011Revenue:(unaudited)Research and development revenueunder collaborative agreements$21,818
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
3. Halozyme Reports First Quarter 2012 Financial Results
4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. IRIDEX Reports 2012 First Quarter Results
7. Cambrex Reports First Quarter 2012 Results
8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
11. Neuland Labs Reports Financial Results For Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
(Date:2/26/2015)... 27, 2015 RnRMarketResearch.com adds ... research report to its store. This report p ... pipeline. The report "Corneal Ulcers - Pipeline Review, ... development for Corneal Ulcers. Corneal Ulcers are primarily ... infections, viral infections & fungal infections. The symptoms ...
(Date:2/26/2015)... Feb. 26, 2015  IRIDEX Corporation (NASDAQ: IRIX ... and full year 2014 financial results after the market closes ... the release, the Company will host a conference call with ... Thursday, March 5, 2015 to discuss the ... Interested parties may access the live conference call via telephone ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
(Date:2/28/2015)... 28, 2015 1Heart Caregiver Services ... emerging brand at Houston Texas Franchise Expo South ... sending its executive delegates headed by Vice-President of ... and Training Randolph Clarito. , Franchise Expo South, ... last February 4-7 and featured Franchise brands of ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Wireless ... management services, and one of the founders ... support for Bell Mobility within their CLEAN Platform™ ... services. Wireless Analytics’ newly developed Bell Mobility ... for the Canadian wireless carrier’s business customers. , ...
(Date:2/27/2015)... A new study published in the Journal ... cycle on a regular basis and prostate cancer. While cycling ... the more hours per week a man spends cycling, the ... an increased importance on prostate cancer screening methods. , “This ... closely at patents’ risk factors for developing prostate cancer,” says ...
(Date:2/27/2015)... Those who self-injure, commonly ... misdiagnosed and therefore aren’t receiving effective treatment ... Jacksonville-based addiction treatment center Lakeview Health has ... Lakeview Professional Lecture Series to counselors, physicians, ... complicated condition. , “Self-injurious behaviors ...
(Date:2/27/2015)... On March 2-4, the Mesothelioma ... Cancer Institute (NCI) will co-host the annual International ... of Health (NIH), in Bethesda, Maryland. The event ... medical professionals and scientists who specialize in mesothelioma, ... public, including patients, their families, and caregivers. , ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3
... Inc. (NASDAQ:,BLUS; TSX: BLU, formerly known as Neurochem Inc.) ... The Company reported a net loss of,$12,902,000 ($0.26 per ... for the same period the previous year. The decrease ... in research and development (R&D),expenses, before research tax credits ...
... FRANCISCO, May 5 Drawing on fifteen ... a leading strategic,consultancy serving the Biotech, pharmaceutical, ... of their new website,showcasing more than 25 ... WWMR, Inc. is a marketing research and ...
... some benefit, but more research needed, study says , , MONDAY, ... ibuprofen regularly for five years may be less likely to ... , And more generally, people using the class of drugs ... risk for Alzheimer,s as well, although the link here is ...
... test scores , , MONDAY, May 5 (HealthDay News) -- Children ... life or longer scored nearly six points higher on IQ ... breast-fed exclusively, a new study has found. , The finding ... who were breast-fed as infants scored better on IQ tests ...
... Medical Center have shown a connection between early drinking ... in adulthood, in a study of adolescent rats. , ... a few exposures to alcohol, said Nicole L. Schramm-Sapyta, ... Biology at Duke University School of Medicine. Rats that ...
... today urged the Senate to immediately enact Pennsylvania Access ... an analysis shows the,proposal is financially sound and stable., ... Budget Office,proves that we have the funds to do ... them access to affordable health insurance,through PA ABC; and ...
Cached Medicine News:Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 2Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 3Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 4Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 5Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 6Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 7Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 8Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 9Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 10Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 11Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 12Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 13Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 14Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 15Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 16Health News:BELLUS HEALTH reports results for first quarter of fiscal 2008 17Health News:WWMR, Inc. Announces New Website to Showcase Research Case Studies 2Health News:Ibuprofen Linked to Reduced Alzheimer's Risk 2Health News:Ibuprofen Linked to Reduced Alzheimer's Risk 3Health News:Breast-Feeding May Boost IQ 2Health News:Breast-Feeding May Boost IQ 3Health News:Preference for alcohol in adolescence may lead to heavy drinking 2Health News:PA Governor Says Financial Analysis Shows Nothing Stands in Way of Senate Action to Help Pennsylvania's Uninsured 2
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical micr...
Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras fo...
... The Optronics MicroFire - Monochrome: ... Monochrome microscope camera with Firewire ... high-efficiency imaging beyond 900nm. The ... with a C-mount adapter and ...
Medicine Products: